Man Group’s Genomic Health, Inc. GHDX Stock Holding History

Man Group’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-201,236	Closed	-$13.6M	–	1982
2019 Q3	$13.6M	Sell	201,236 -640,744	-76%	-$44M	0.05%	433
2019 Q2	$49M	Buy	841,980 +270,999	+47%	+$16.1M	0.18%	125
2019 Q1	$40M	Buy	570,981 +291,160	+104%	+$21.6M	0.15%	143
2018 Q4	$18M	Sell	279,821 -151,477	-35%	-$10.6M	0.08%	280
2018 Q3	$30.3M	Buy	431,298 +121,658	+39%	+$7.12M	0.11%	194
2018 Q2	$15.6M	Buy	309,640 +42,864	+16%	+$1.7M	0.06%	355
2018 Q1	$8.35M	Buy	+266,776	New	+$8.85M	0.04%	575

Man Group's GHDX Position: Q4 2019 in Review

Man Group sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 201,236 shares — an estimated $13.6M sold.

Man Group first reported a position in GHDX in Q1 2018 and held it in 7 quarters. The position peaked at $49M in Q2 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Man Group reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Man Group sold 201,236 Genomic Health, Inc. shares in Q4 2019, an estimated $13.6M.
Man Group first reported a position in Genomic Health, Inc. in Q1 2018 and held it in 7 quarters.
Man Group's Genomic Health, Inc. position peaked at $49M in Q2 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Man Group's 13F filing for Q4 2019, filed 18 Feb 2020.